BREAST CANCER BASE

Breast hyperplasia and breast cancer in the clinical manifestations are mainly to mass in the pathogenesis there are similarities, but some types of breast hyperplasia can develop into breast cancer. Hyperplasia and breast cancer is a complex issue, although 150 have been studied for many years, but until now, not yet fully clear, we believe that these two diseases from the following aspects to understand.

We must clearly these two diseases have a qualitatively different. Breast hyperplasia is a benign, non-neoplastic diseases. Breast cancer is breast cancer. Both diseases treatment, prognosis very different. In this understanding, on the basis of our discussion that the relationship between the two.

Breast lobular hyperplasia neither inflammatory nor tumors, breast tissue is physiological subinvolution hyperplasia and the normal tissue disorder, and the performance of the menstrual cycle-related breast tenderness, it can also obscure the mass, usually with the menstrual cycle changes dissipated. This is a common disease, 70% -80% of women have had. General clear symptoms were not treated, symptoms can be oral vitamin E, for the pain even more patients will be anti-inflammatory painkillers such as expectant treatment. Clinical showed that only 1% of lobular hyperplasia malignant transformation will happen, no need to worry too much about lesbians.

Although breast hyperplasia is a benign breast lesions, a general proposition conservative treatment, but as mentioned above, because of its close ties with breast cancer, clinical certain malignant rate, so when mammary hyperplasia following some cases, it is recommended patients to specialists Department received surgical treatment.

(1) proliferative breast lesions confined to a single quadrant of the breast, especially in the breast outside the quadrant; Tumor size, qulaity, conservative treatment were ineffective.

(2) the age of 35 and above, with maternal family history of breast cancer and breast lumps were nodular, the types of treatment were not significantly narrowed.

Recent studies show : from inside the organization, not associated with breast ductal hyperplasia pure lobular hyperplasia, breast hyperplasia total of 70%, will not turn into breast cancer. Accompanied by ductal hyperplasia, but the same type epithelial cells of the mammary hyperplasia 20%, the rate of malignant transformation of a ~ 2%. Ductal Hyperplasia, epithelial cells were mildly abnormal breast hyperplasia, malignant transformation rate of 2-4%. Ductal Hyperplasia, if the epithelial cells of severe dysplasia, although the incidence rate of only 5%, but malignant rate of 75% -100%. Therefore, although only a handful of proliferative breast cancer can occur, it should not be prevented and every three months or six months to go to the hospital to be reviewed. If there is a limited scope of the unilateral disease, or breast nodules increased stiffen the short term, should be more alert. Before and after menopause and elderly patients, especially those with family history of breast cancer, they should always check to the hospital, if necessary, the need for needle aspiration cytology or histologic examination, breast "B" - ultrasound and mammography, also aided diagnosis to be found pre-cancerous lesions, the timely processing job seekers.